儿童重症肺炎支原体肺炎的诊治进展  

Progress in the diagnosis and treatment of severe pediatric Mycoplasma pneumoniae pneumonia

作　　者：王亨 刘金荣[1] 赵顺英[1] Wang Heng;Liu Jinrong;Zhao Shunying(DepartmentⅡof Respiratory Medicine,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China)

机构地区：[1]国家儿童医学中心,首都医科大学附属北京儿童医院呼吸二科,北京100045

出　　处：《中华实用儿科临床杂志》2023年第11期842-845,共4页Chinese Journal of Applied Clinical Pediatrics

基　　金：北京市医院管理中心"扬帆"计划重点医学专业项目(ZYLX202118)。

摘　　要：近年来,东亚国家特别是我国报道的学龄期儿童肺炎支原体肺炎(MPP)重症及耐药病例数量在增多。儿童MPP是异质性疾病,部分患儿感染后为自限性过程,部分患儿感染后病情重且迁延,容易遗留下气道闭塞的后遗症,导致这部分患儿肺功能减退,生活质量下降。虽然目前我国尚无儿童MPP的全国流行病学数据,但基于我国学龄期儿童人口基数大,以及MPP遗留下气道闭塞的长期影响,MPP应被视为我国学龄期儿童主要的呼吸系统疾病并加以重视。现主要就肺炎支原体耐药与重症MPP的关系,以及MPP的分型和治疗进行简要概述。In recent years,the number of severe and drug-resistant Mycoplasma pneumoniae pneumonia(MPP)in school-aged children in East Asian countries is on the rise,especially in China.Pediatric MPP is a heterogeneous disease.Some MPP children have a self-limited progression after infection,while some suffer an aggravated and prolonged course of disease.The sequelae of airway occlusion leads to the declines of lung function and quality of life.Although a series of nationally epidemiological data on pediatric MPP in China are scant,pediatric MPP should be regarded as the highly concerned main respiratory disease of school-aged children due to the large population of children in China and the long-term effects of MPP-induced airway occlusion.This article briefly reviews the correlation between Mycoplasma pneumoniae resistance and severe MPP,as well as the classification and treatment of MPP.

关 键 词：肺炎支原体肺炎 大环内酯类耐药 重症 分型 靶向治疗 儿童 

分 类 号：R725.6[医药卫生—儿科]